David L. Porter
Impact in
- Oncology top 0.02%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 0.2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 140
- CAR-T cell therapy research 116
- Hematology 57
- Hematopoietic Stem Cell Transplantation 36
- Acute Myeloid Leukemia Research 22
- Co-authors
- Carl H. JuneBruce L. LevineStephan A. GruppMichael KalosAdam BaggNoelle V. FreyDavid T. TeacheyDavid M. Barrett
- Journals
- Blood (62 papers)Journal of Clinical Oncology (18 papers)Biology of Blood and Marrow Transplantation (18 papers)American Journal of Hematology (8 papers)Transplantation and Cellular Therapy (7 papers)
- Partner nations
- United StatesSpainSwitzerland
In The Last Decade
David L. Porter
200 papers receiving 19.1k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Oncology 16.2k
- Immunology 6.3k
- Genetics 4.9k
- Hematology 2.0k
- Genetics 1.1k
Countries citing papers authored by David L. Porter
This map shows the geographic impact of David L. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Porter more than expected).
Fields of papers citing papers by David L. Porter
This network shows the impact of papers produced by David L. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Porter. The network helps show where David L. Porter may publish in the future.
Co-authors
The 25 scholars most cited alongside David L. Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2022 | 8 | |
| 3 | 2022 | 53 | |
| 4 | 2022 | 2 | |
| 5 | 2020 | 11 | |
| 6 | 2017 | 92 | |
| 7 | Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas Hit paper breakdown → | 2017 | 1266 |
| 8 | 2016 | 63 | |
| 9 | CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia Hit paper breakdown → | 2015 | 521 |
| 10 | 2015 | 118 | |
| 11 | 2014 | 363 | |
| 12 | 2013 | 18 | |
| 13 | Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia Hit paper breakdown → | 2013 | 2631 |
| 14 | 2009 | 36 | |
| 15 | 2008 | 29 | |
| 16 | 2003 | 4 | |
| 17 | 2003 | 7 | |
| 18 | 2002 | 43 | |
| 19 | 2002 | 15 | |
| 20 | 1998 | 1 |
About David L. Porter
David L. Porter is a scholar working on Oncology, Hematology, Genetics, Immunology and Transplantation, having authored 206 papers that have together received 19.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (116 papers), Hematopoietic Stem Cell Transplantation (36 papers), Chronic Lymphocytic Leukemia Research (30 papers), Acute Lymphoblastic Leukemia research (29 papers), Acute Myeloid Leukemia Research (22 papers), Lymphoma Diagnosis and Treatment (21 papers), Immune Cell Function and Interaction (20 papers) and Virus-based gene therapy research (18 papers). The work is most often cited by research in Oncology (16.2k citations), Immunology (6.3k citations), Genetics (4.9k citations), Hematology (2.0k citations) and Genetics (1.1k citations). David L. Porter has collaborated with scholars based in United States, Spain and Switzerland. Frequent co-authors include Carl H. June, Bruce L. Levine, Stephan A. Grupp, Michael Kalos, Adam Bagg, Noelle V. Frey, David T. Teachey, David M. Barrett, Shannon L. Maude and Anne Chew. Their work appears in journals such as Blood, Journal of Clinical Oncology, Biology of Blood and Marrow Transplantation, American Journal of Hematology and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.